This World Lung Day, Verona Pharma is raising awareness of the debilitating burden of respiratory diseases, most specifically Chronic Obstructive Pulmonary Disease (COPD), which affects more than 384 million patients and is the third leading cause of death worldwide. What is COPD and what are the current treatments available to those patients suffering with progressive […]
Tag Archive for: Q&A
In our first Investor Q&A article, Roel Bulthuis, Managing Partner of INKEF Capital shares his thoughts on the investment landscape in Europe.
Since taking over as CEO of Calliditas Therapeutics in 2017, Renee Aguiar-Lucander has taken the biotech through an IPO in Stockholm and commenced a pivotal phase 3 trial plus major licensing deals and a secondary fund raise. She has established a US presence, made transformational regulatory milestones, and this month completed a successful upsized US […]
Watch the full interview here Mike Ward, Global Head of Thought Leadership, Decision Resources Group, Clarivate, speaks to Cedric about his inspiration and interesting challenges building Apellis Pharmaceuticals “If you are an entrepreneur, you are conceptualising the improbable” To watch the highlights reel click the thumbnail below link to full 35min interview above. Dr. Cedric […]